follow up of Effects of Melatonin on Health-Related Quality of Life

Phase 2

• Conditions: Breast Cancer; Malignant neoplasm of breast; Health Related Quality of Life; Melatonin.

• Registration Number: IRCT20221205056712N1
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 64

Inclusion Criteria

Breast Cancer Stages I, II, III According to Pathological Reports
Patients at least 18 Years Old Have Signed a Written Consent
Receiving Adjuvant Chemotherapy and Radiotherapy

Exclusion Criteria

Not signing a written consent
Untreated Hypercalcemia
Systolic Blood Pressure Less Than 100 mm Hg
Warfarin Consumption
Methylphenidate Consumption
Consumption of sleep Pills During Melatonin Use
TSH>5/5 or <0/5
Pregnancy or Breastfeeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life. Timepoint: 3 years after last adjuvant treatment session. Method of measurement: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30).